-
Triptolide (PG490) for Cancer Research
2026-08-29
Triptolide (PG490) is a nanomolar transcriptional modulator for studying tumor invasion, immune-cell apoptosis, and inflammatory matrix remodeling. This practical guide connects product handling with assay design and the emerging biology of transcription condensates and S-phase genome stability.
-
Pyridostatin TFA: G-Quadruplex Research Workflows
2026-08-28
Pyridostatin TFA gives researchers a practical way to stabilize G-quadruplexes while linking telomere biology, cancer assays, and emerging protein-condensation studies. This guide turns the compound’s reported handling parameters into controlled workflows, assay choices, and troubleshooting strategies.
-
CA2 Perineuronal Nets and Social Memory in Alzheimer’s
2026-08-28
A 2025 study identifies degradation of hippocampal CA2 perineuronal nets as a causal contributor to social cognition memory loss in the 5XFAD Alzheimer’s disease mouse model. By combining anatomical, transcriptomic, behavioral, genetic, enzymatic, and pharmacological approaches, the work links MMP-dependent extracellular matrix remodeling to circuit-level memory dysfunction and suggests PNN preservation as a testable intervention strategy.
-
Nocodazole as a Mechanistic Control in Entry Assays
2026-08-27
Nocodazole is more than a microtubule polymerization inhibitor for mitotic arrest. This article explains how its carefully bounded use can distinguish cytoskeletal dependence from clathrin-mediated, dynamin-dependent viral entry and improve interpretation of trafficking, cell-cycle, and cancer research assays.
-
ECL Chemiluminescent Substrate Detection Kit Guide
2026-08-27
Learn how hypersensitive HRP-based detection can strengthen immunoblotting of PRDX5 and other low-abundance targets in retinal ischemia-reperfusion models. This workflow combines practical membrane handling, exposure control, and troubleshooting for reliable western blot chemiluminescent detection.
-
Lamotrigine in Neurocardiac Assays
2026-08-26
Lamotrigine provides a mechanistically anchored comparator for linking sodium-channel pharmacology, serotonin signaling, and cardiac electrophysiology. This workflow shows how to combine concentration-response phenotyping with transcriptomics while controlling solubility, vehicle, and cytotoxicity artifacts.
-
ICG001: Wnt/β-Catenin Pathway Inhibitor
2026-08-26
ICG001 is a selective Wnt/β-catenin pathway inhibitor that disrupts β-catenin binding to CBP without targeting p300. Its research applications include TCF/β-catenin transcription inhibition, colon carcinoma models, glioblastoma stem-cell assays, and experimental fibrosis studies.
-
Sulfachloropyridazine in E. tenella Cecal Omics
2026-08-25
The reference study integrates 16S rRNA sequencing with LC-MS/MS metabolomics to examine how ethanamizuril, Sulfachloropyridazine, and their combination affect chickens infected with Eimeria tenella. Its findings connect anticoccidial treatment with drug-specific changes in cecal microbial structure and metabolism, while also showing why low-dose combinations require microbiome-aware evaluation.
-
Estradiol Benzoate: From ERα Mechanism to Translation
2026-08-25
A mechanism-first guide to using Estradiol Benzoate in estrogen receptor alpha agonist assays, with practical handling guidance, translational decision points, and a carefully bounded comparison to structure-based antiviral discovery.
-
TDRD9 siRNA Nanoparticles in P. aeruginosa Lung Injury
2026-08-24
The reference study identifies TDRD9 as a regulator of neutrophil cuproptosis during Pseudomonas aeruginosa lung infection and develops hyaluronic acid-coated peptide nanoparticles to deliver TDRD9-targeting siRNA. Across mouse and human lung organoid models, this approach reduced neutrophil-driven inflammation, pulmonary injury, and bacterial growth, supporting immune-cell death modulation as a potential adjunct strategy for difficult bacterial pneumonia.
-
GM 6001: Designing Better MMP Assays
2026-08-24
GM 6001 (Galardin) is a broad-spectrum MMP inhibitor for dissecting extracellular matrix remodeling, receptor signaling, and migration phenotypes. This article develops an assay-design framework informed by a recent lysosomal cell-death study, helping researchers distinguish direct MMP effects from downstream cellular responses.
-
Bismuth Subsalicylate in GI Apoptosis Assays
2026-08-23
Bismuth Subsalicylate enables a practical bridge between gastrointestinal disorder research and quantitative membrane-injury assays. This guide combines formulation-aware handling with annexin V flow cytometry and microscopy to help researchers distinguish inflammation pathway modulation from nonspecific cell damage.
-
Stromal Remodeling Nanomedicine in Pancreatic Cancer
2026-08-22
The reference study develops an acid-responsive, rocket-like nanomedicine that sequentially releases Halofuginone and IPR-803 before delivering gemcitabine-loaded silica nanoparticles. By targeting both fibrotic stroma and angiogenic remodeling, the platform improved intratumoral drug penetration and produced marked tumor regression in a pancreatic cancer model.
-
Doxycycline: Mechanisms and AAA Research
2026-08-22
Doxycycline is a tetracycline antibiotic with antimicrobial activity and research-relevant metalloproteinase inhibition. Recent targeted delivery work shows how doxycycline nanoparticles can address multiple abdominal aortic aneurysm mechanisms while reducing exposure-related toxicity in animal studies.
-
Catalpol in Cancer: Mechanisms and Evidence
2026-08-21
The 2025 review by Laurindo and colleagues synthesizes preclinical evidence that catalpol, an iridoid glycoside, can affect cancer-cell proliferation, apoptosis, migration, inflammation, and angiogenesis across multiple tumor models. Its main value is mechanistic integration, while the absence of clinical trials and substantial heterogeneity between studies limit conclusions about efficacy, dosing, and translation.